Stockscreener 앱 받기
26.04
2.80%
-0.76
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential - Seeking Alpha
Could Viking Therapeutics Become the Next Eli Lilly? - Yahoo Finance
3 Best Growth Stocks to Buy in June - The Motley Fool
Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside? - MSN
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - Yahoo Finance
SA analyst upgrades: NVDA, DJT, VKTX, BRK.A, BEAM (NVDA:NASDAQ) - Seeking Alpha
Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade) - Seeking Alpha
Viking Therapeutics to Participate at Upcoming Investor Conferen - GuruFocus
Viking Therapeutics to Participate at Upcoming Investor Conferences | VKTX Stock News - GuruFocus
Viking Therapeutics Lines Up Presentations at Goldman Sachs, William Blair Healthcare Conferences - Stock Titan
Viking Therapeutics Holds Annual Stockholders Meeting - TipRanks
Viking Therapeutics: Buy It For The Future And Ignore The Noise (NASDAQ:VKTX) - Seeking Alpha
(VKTX) On The My Stocks Page - news.stocktradersdaily.com
Better Weight Loss Stock: Amgen or Viking Therapeutics? - MSN
Viking Therapeutics: Weight-Loss Story Remains Intact (NASDAQ:VKTX) - Seeking Alpha
Bank of America Corp DE Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? - AOL.com
Viking Therapeutics: A High Potential Biotech Play With Manageable Risks (NASDAQ:VKTX) - Seeking Alpha
Viking Therapeutics: Near-Term Catalysts And Competitor Readouts - Seeking Alpha
BNP Paribas Financial Markets Has $1.88 Million Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Viking Therapeutics (VKTX) Stock Rises Amid Novo Nordisk CEO Cha - GuruFocus
Why Viking Therapeutics Stock Bumped 3% Higher Today - Mitrade
When (VKTX) Moves Investors should Listen - news.stocktradersdaily.com
Viking Therapeutics Stock May Struggle After As-Expected Report - MSN
2 Monster Stocks in the Making to Buy Now and Hold for 10 Years - The Motley Fool
Dimensional Fund Advisors LP Has $4.06 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of “Buy” by Analysts - Defense World
Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips - The Globe and Mail
3 Monster Stocks in the Making - Yahoo Finance
Hsbc Holdings PLC Sells 9,437 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - Defense World
Why Viking Therapeutics (VKTX) Stock is Gaining Today - GuruFocus
Why Viking Therapeutics Stock Surged Nearly 20% Higher in April - Yahoo
Viking Therapeutics (VKTX) Sees Unusual Options Activity | VKTX Stock News - GuruFocus
Why Viking Therapeutics Stock Surged Nearly 20% Higher In April - Barchart.com
Why Viking Therapeutics Stock Was Victorious This Week - MSN
(VKTX) Investment Report - news.stocktradersdaily.com
Viking Therapeutics (VKTX) Sees 20% Stock Surge Despite Financial Losses - GuruFocus
Why Viking Therapeutics (VKTX) Stock is Rising Today - GuruFocus
Viking Therapeutics call volume above normal and directionally bullish - TipRanks
Viking Therapeutics (VKTX) Sees Surge in Call Options Trading | VKTX Stock News - GuruFocus
Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025 - simplywall.st
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday - The Globe and Mail
1.76%
0.89%
자본화:
|
볼륨(24시간):